MedPath

An Observational Study on Long-Term Efficacy and Safety of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis (FAct)

Completed
Conditions
Rheumatoid Arthritis
Registration Number
NCT01483326
Lead Sponsor
Hoffmann-La Roche
Brief Summary

This observational study will evaluate the long-term efficacy and safety of RoActemra/Actemra (tocilizumab in participants of the ACT SURE clinical trial and further patients with moderate to severe rheumatoid arthritis starting or receiving RoActemra/Actemra. Data will be collected from each patient for up to 4 years.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
215
Inclusion Criteria
  • Adult patients, >18 years of age
  • Participants in the ACT-SURE trial, or patients with moderate to severe rheumatoid arthritis starting or receiving RoActemra/Actemra
Exclusion Criteria
  • Contra-indications for RoActemra/Actemra

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in disease activity score (DAS 28)baseline and up to 4 years
Secondary Outcome Measures
NameTimeMethod
Change in concomitant medication (especially tapering of steroids)baseline and up to 4 years
Safety: Incidence of adverse eventsup to 4 years
Response (DAS 28) according to patient-related factors (C-reactive protein, rheumatoid factor, inadequate response to anti-TNF/DMARDs, duration of illness)up to 4 years
Change in disability, assessed by Health Assessment Questionnaire (HAQ)baseline and up to 4 years
Change in dosage schedule (modification/interruption/discontinuation)baseline and up to 4 years

Trial Locations

Locations (19)

Jan Van Breemen Instituut

🇳🇱

Amsterdam, Netherlands

Gelre Ziekenhuis; Reumatology

🇳🇱

Apeldoorn, Netherlands

Rijnstate Ziekenhuis; Afdeling Reumatologie

🇳🇱

Arnhem, Netherlands

Amphia ziekenhuis, locatie langendijk

🇳🇱

Breda, Netherlands

Leyenburg Ziekenhuis; Internal Medecine

🇳🇱

Den Haag, Netherlands

Deventer ziekenhuis

🇳🇱

Deventer, Netherlands

MC groep - locatie Emmeloord

🇳🇱

Emmeloord, Netherlands

Scheper Ziekenhuis

🇳🇱

Emmen, Netherlands

Medisch Centrum Twente; Rheumatology

🇳🇱

Enschede, Netherlands

Groene Hart Ziekenhuis

🇳🇱

Gouda, Netherlands

Scroll for more (9 remaining)
Jan Van Breemen Instituut
🇳🇱Amsterdam, Netherlands

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.